Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to γ-glutamyl transpeptidase activity

被引:24
作者
Bessede, G [1 ]
Miguet, C [1 ]
Gambert, P [1 ]
Neel, D [1 ]
Lizard, G [1 ]
机构
[1] CHU, Hop Bocage, INSERM, U498,Lab Biochim Med, F-21034 Dijon, France
关键词
HUVECs; ECV304; cells; Hcy; gamma-GT;
D O I
10.1096/fj.00-0848com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperhomocysteinemia represents an independent risk factor for atherosclerosis, but the mechanisms leading to cellular dysfunctions remain unknown. Using ECV304 cells, we found that homocysteine (Hcy) plus copper (Cu2+) induced cytotoxic effects: loss of cell adhesion, increased permeability to PI, and the occurrence of morphologically apoptotic cells. This form of apoptosis, inhibited by Z-VAD-fmk, was associated with a loss of mitochondrial potential, a cytosolic release of cytochrome c, activation of caspase-3, degradation of poly( ADP-ribose) polymerase, and internucleosomal DNA fragmentation. However, the ability of Hcy plus Cu2+ to induce apoptosis decreased when the pretreatment culture time increased. As a positive correlation was found between the length of time of culture before treatment and the enhancement of gamma -glutamyl transpeptidase (gamma -GT) activity, we asked whether gamma -GT was involved in the control of Hcy plus Cu2+-induced apoptosis. Therefore, ECV304 cells were treated with either acivicin or dexamethasone, inhibiting and stimulating gamma -GT, respectively. In ECV304 cells and human umbilical venous endothelial cells, acivicin favored Hcy plus Cu2+-induced apoptosis whereas dexamethasone counteracted the apoptotic process. As acivicin and dexamethasone were also capable of modulating cell death in ECV304 cells treated with antitumoral drugs, our data emphasize that the involvement of gamma -GT in the control of apoptosis is not restricted to Hcy but also concerns other chemical compounds.
引用
收藏
页码:1927 / 1940
页数:14
相关论文
共 83 条
[1]   GAMMA-GLUTAMYL-TRANSFERASE TRANSPEPTIDASE (GAMMA-GT) AND MAINTENANCE OF THIOL POOLS IN TUMOR-CELLS RESISTANT TO ALKYLATING-AGENTS [J].
AHMAD, S ;
OKINE, L ;
WOOD, R ;
ALJIAN, J ;
VISTICA, DT .
JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 131 (02) :240-246
[2]   DAUNORUBICIN AND DOXORUBICIN, ANTHRACYCLINE ANTIBIOTICS, A PHYSICOCHEMICAL AND BIOLOGICAL REVIEW [J].
AUBELSADRON, G ;
LONDOSGAGLIARDI, D .
BIOCHIMIE, 1984, 66 (05) :333-352
[3]   Quantitation of homocysteine in human plasma by capillary electrophoresis and laser-induced fluorescence detection [J].
Caussé, E ;
Terrier, R ;
Champagne, S ;
Nertz, M ;
Valdiguíe, P ;
Salvayre, R ;
Couderc, F .
JOURNAL OF CHROMATOGRAPHY A, 1998, 817 (1-2) :181-185
[4]  
Chango A, 1999, ANN BIOL CLIN-PARIS, V57, P37
[5]  
CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155
[6]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[7]   CONFLUENCE-DEPENDENT RESISTANCE IN HUMAN COLON CANCER-CELLS - ROLE OF REDUCED DRUG ACCUMULATION AND LOW INTRINSIC CHEMOSENSITIVITY OF RESTING CELLS [J].
DIMANCHEBOITREL, MT ;
PELLETIER, H ;
GENNE, P ;
PETIT, JM ;
LEGRIMELLEC, C ;
CANAL, P ;
ARDIET, C ;
BASTIAN, G ;
CHAUFFERT, B .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (05) :677-682
[8]  
Dirks WG, 1999, IN VITRO CELL DEV-AN, V35, P558
[9]  
DOROSZ P, 1995, GUIDE PRATIQUE MED, P1512
[10]   DISORDERED METHIONINE HOMOCYSTEINE METABOLISM IN PREMATURE VASCULAR-DISEASE - ITS OCCURRENCE, COFACTOR THERAPY, AND ENZYMOLOGY [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
WANG, J ;
LYNCH, JF ;
MACEY, D ;
LUNDBERG, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (09) :1253-1260